Fundz

MeiraGTx Appoints Alan M. Sebulsky as Class I Director

PUBLIC · MGTXSep 23, 2026

Position

Director

Company

MeiraGTx Holdings plc

Alan M. Sebulsky
New YorkBiotechnologyHealth CareGeneticsTherapeutics

Description

On September 22, 2026, MeiraGTx Holdings plc appointed Alan M. Sebulsky to the Board as a Class I director. His term will expire at the Company’s 2028 annual meeting of shareholders, consistent with the norm for Class I directors

Quick answer

MeiraGTx Appoints Alan M. Sebulsky as Class I Director (September 23, 2026). MeiraGTx Holdings plc is based in New York, New York, United States.

Who is the new Director at MeiraGTx Holdings plc?
MeiraGTx Holdings plc named Alan M. Sebulsky Director, announced September 23, 2026.
What did MeiraGTx Holdings plc announce on September 23, 2026?
On September 22, 2026, MeiraGTx Holdings plc appointed Alan M. Sebulsky to the Board as a Class I director.
What does MeiraGTx Holdings plc do?
MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs.
Where is MeiraGTx Holdings plc based?
MeiraGTx Holdings plc is based in New York, New York, United States.
Which similar companies made leadership changes around the same time?
BioMarin Pharmaceutical (October 5, 2026), Genetix Biotherapeutics (October 19, 2026), Crispr Therapeutics (October 19, 2026) and Corcept (September 23, 2026) also announced leadership changes within 45 days of MeiraGTx Holdings plc.

Source: Fundz verified event record.

Other recent leadership changes in Genetics and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at MeiraGTx Holdings plc, and when

A new leader at MeiraGTx Holdings plc brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day MeiraGTx Holdings plc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MeiraGTx Holdings plc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MeiraGTx Holdings plc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MeiraGTx Holdings plc

Location

States 450 East 29Th Street

New York, New York, United States

About

MeiraGTx (Nasdaq: MGTX) is a vertically integrated, clinical-stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, and a transformative gene regulation platform technology that allows precise, dose-responsive control of gene expression by oral small molecules with dynamic range that can exceed 5000-fold. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring, and developing technologies that give depth across both product candidates and indications. MeiraGTx’s initial focus is on three distinct areas of unmet medical need: ocular diseases, including both inherited retinal diseases as well as large degenerative ocular diseases, neurodegenerative diseases, and severe forms of xerostomia. Though initially focusing on the eye, central nervous system, and salivary gland, MeiraGTx plans to expand its focus to develop additional gene therapy treatments for patients suffering from a range of serious diseases. For more information, please visit www.meiragtx.com

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MeiraGTx Holdings plc changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Sarah
Senior decision-maker at this company
••••••••@••••••••

See Sarah's verified email →

Oliver
Likely contact at this company
••••••••@••••••••

See Oliver's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for MeiraGTx Holdings plc's next move

Learn about Strategic plan

MeiraGTx Holdings plc changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.